A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

NCT07384975 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa (HS)

Interventions

DRUG: NAV-240
DRUG: Placebo to match NAV-240

Sponsor

Navigator Medicines, Inc.